Related Articles
Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer
Plasma proteome predicts chemotherapy response in osteosarcoma patients
Histological evaluations of primary lesions are independently associated with prognosis in patients with gastric cancer who receive neoadjuvant chemotherapy
Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB
99mTc-sestamibi scintigraphy used to evaluate tumor response to neoadjuvant chemotherapy in locally advanced breast cancer: A quantitative analysis